Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 8:29 a.m.	oms	The number of symptomatic COVID-19 infections will be compared between participants randomised to chloroquine or hydroxychloroquine; and placebo groups between baseline and 90 days	The number of symptomatic COVID-19 infections will be compared between participants randomised to chloroquine or hydroxychloroquine; and placebo groups between baseline and 90 days